Why Did SoFi Stock Drop?
Fintech platform SoFi (NASDAQ:SOFI) has stumbled in recent days, selling…
Sell
46
MLTX Quote, Financials, Valuation and Earnings
Last price:
$14.89
Seasonality move
:
19.6%
Day range:
$14.84 - $15.34
52-week range:
$5.95 - $62.75
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
3.65x
Volume:
1.3M
Avg. volume:
2.2M
1-year change:
-72.15%
Market cap:
$1.1B
Revenue:
--
EPS (TTM):
-$3.33
Earnings Data
Next earnings date for MLTX
Feb 26
2026
Most recent earnings per share
-$1.10
Missed by $0.19
(Nov 5/2025)
Consensus Estimate
-$0.92
(Nov 5/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
MLTX Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 02/26/2026 | Q4 | -- | -- | -- | -$0.99 | -- |
| 11/05/2025 | Q3 | -- | -- | -$1.10 | -$0.92 | -$0.19 |
| 08/05/2025 | Q2 | -- | -- | -$0.87 | -$0.76 | -$0.11 |
| 05/07/2025 | Q1 | -- | -- | -$0.63 | -$0.74 | $0.10 |
| 02/26/2025 | Q4 | -- | -- | -$0.72 | -$0.59 | -$0.13 |
| 11/07/2024 | Q3 | -- | -- | -$0.56 | -$0.45 | -$0.11 |
| 08/07/2024 | Q2 | -- | -- | -$0.39 | -$0.28 | -$0.10 |
| 05/07/2024 | Q1 | -- | -- | -$0.22 | -$0.21 | -$0.01 |
| 02/29/2024 | Q4 | -- | -- | -$0.12 | -$0.27 | $0.14 |
| 11/14/2023 | Q3 | -- | -- | -$0.18 | -$0.25 | $0.07 |
| 08/10/2023 | Q2 | -- | -- | -$0.23 | -- | -- |
| 05/11/2023 | Q1 | -- | -- | -$0.23 | -- | -- |
| 03/20/2023 | Q4 | -- | -- | -$0.31 | -- | -- |
| 11/14/2022 | Q3 | -- | -- | -$0.27 | -- | -- |
| 08/12/2022 | Q2 | -- | -- | -$0.34 | -- | -- |
| 03/31/2022 | Q1 | -- | -- | -$3.17 | -- | -- |
| 12/31/2021 | Q4 | -- | -- | -$1.40 | -- | -- |
| 09/30/2021 | Q3 | -- | -- | -$2.63 | -- | -- |
| 06/30/2021 | Q2 | -- | -- | -$2.90 | -- | -- |
| 03/31/2021 | Q1 | -- | -- | -$0.01 | -- | -- |
| 12/31/2020 | Q4 | -- | -- | -$0.01 | -- | -- |
| 09/30/2020 | Q3 | -- | -- | -$0.00 | -- | -- |
MoonLake Immunotherapeutics Earnings Questions
-
How Much did MoonLake Immunotherapeutics Generate in Revenue Last Quarter?
MoonLake Immunotherapeutics reported -- worth of top line sales in its most recent quarter.
-
Did MoonLake Immunotherapeutics Beat Earnings Last Quarter?
MoonLake Immunotherapeutics announced earnings per share of -$1.10 which represents a miss of analyst forecast a -$0.92 per share.
-
Is MoonLake Immunotherapeutics Profitable?
MoonLake Immunotherapeutics reported -$745K that represents -$0.01 per share over the last quarter.
-
What is the Analyst Consensus for MoonLake Immunotherapeutics EPS Next Year?
MoonLake Immunotherapeutics's earnings are forecast to decrease from -$1.89 per share to -$1.72 per share next year representing a decrease of -89%.
-
When is MoonLake Immunotherapeutics's Earnings Date?
MoonLake Immunotherapeutics's next earnings date is February 26, 2026.
Related Companies
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Robinhood Win AI Investing?
Recently, online brokerage Robinhood (NASDAQ:HOOD) has been focused on introducing…
Is Amazon an AI Stock?
With the market starting to look skittish on pure-play AI…
Stock Ideas
Buy
52
Is NVDA Stock a Buy?
Market Cap: $4.4T
P/E Ratio: 62x
Buy
56
Is AAPL Stock a Buy?
Market Cap: $4.1T
P/E Ratio: 37x
Buy
81
Is GOOG Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 40x
Alerts
Buy
56
SMX alert for Dec 8
SMX (Security Matters) Plc [SMX] is down 48.08% over the past day.
Buy
62
PRAX alert for Dec 8
Praxis Precision Medicines, Inc. [PRAX] is up 6.66% over the past day.
Sell
13
PSN alert for Dec 8
Parsons Corp. [PSN] is down 6.48% over the past day.
